Zilkha Neurogenetic Institute
About the Institute
The Zilkha Neurogenetic Institute (ZNI) is one of the Centers of Excellence at the Keck School of Medicine of USC. Established in 2003 with a gift from Selim Zilkha, the Zilkha Neurogenetic Institute is a world leader for basic neuroscience research, with a multi-disciplinary team of outstanding faculty whose collaboration concentrates on the causes, effects of and therapies for neurodegenerative disease and psychiatric disorders.
Students work with world leading researchers in various disciplines to conduct world-class bench science with some clinical applications and translational work to investigate and identify the underlying circuitry or mechanisms of the brain that are influenced or affected by neurodegenerative conditions such as Alzheimer’s, Huntington’s disease, schizophrenia, autism, Down Syndrome and hearing and visual disorders. The research experience takes place in a vibrant and dynamic community with access to a variety of state-of-the-art labs and numerous resources.
Zlokovic receives nearly $25 million to study Alzheimer’s diseaseBerislav Zlokovic, MD, PhD, a pioneer of the theory that fixing the brain’s leaky blood vessels will prevent Alzheimer’s disease, has received four grants totaling up to $24.9 million over five years. The funding allows Zlokovic, director of the Zilkha Neurogenetic Institute, to attack from different fronts the blood-brain barrier, a gatekeeper that prevents toxic
View All ZNI Events
Keck School Events
01/27/2016 - 01/28/2017
Keck School of Medicine, Surgical Skills Simulation and Education Center, 2250 Alcazar Street, Los Angeles
7:30 am - 5:00 pm
View All Events